Articles From: - ANI Pharmaceuticals Schedules Conference Call for Third Quarter 2014 Financial Results to 2014/10/25 - UPDATE: 10 beers you'll be drinking all winter -2-


Prospective blinded study demonstrates ability to accurately determine mutational status and monitor response to BRAF inhibitor therapy from urinary cell-free DNA SAN DIEGO , Oct.
Sign-up for - Clinical Study Using Trovagene's Precision Cancer Monitoring Platform Published in Cancer Discovery investment picks
Kofax® Limited (NASDAQ:KFX) LSE:KFX), a leading provider of smart process applications for the business critical First Mile™ of customer interactions, today announced that Kofax Mobile Capture™ Platform received the 2014 Software of the Year Award from Document Manager (DM) Magazine at the Hotel Russell in London’s Russell Square.
Sign-up for - Kofax Mobile Capture Platform Wins Document Manager Magazine’s 2014 Software of the Year Award investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today reported financial results for the three and nine months ended September 30, 2014, and provided an operating forecast and program updates.
Sign-up for - Ligand Reports Third Quarter 2014 Financial Results investment picks
Data Supports Benefit in Nonsense Mutation Duchenne Muscular Dystrophy Patients SOUTH PLAINFIELD, N.J. , Oct.
Sign-up for - Translarna™ Phase 2b Data Published in Muscle & Nerve investment picks
http://media.marketwire.com/attachments/201101/18142_ScorpioTankersLogo_200pixels.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1154015&ProfileId=051205&sourceType=1 MONACO --
Sign-up for - Scorpio Tankers Inc. Announces Financial Results for the Third Quarter of 2014 and Newbuilding Vessel Deliveries investment picks
First Ebola Vaccine Candidate based on the 2014 Guinea Ebola Strain Genetic Sequence Robust immune responses demonstrated in preclinical studies; exceptional responses when used with Novavax' Matrix-M™ adjuvant Non-human primate study initiated GMP manufacture initiated; Scaled-up manufacturing to begin 1 st quarter 2015 Phase 1 clinical trial anticipated to start in December 2014 GAITHERSBURG, Md., Oct.
Sign-up for - Novavax Announces Ebola Vaccine Development Program at the 8th Vaccine and ISV Conference in Philadelphia investment picks
- HETLIOZ® U.S. sales grew to $5.2 million in the first full quarter since launch - HETLIOZAccess™ Named Patient Program launched in Europe and Canada - Fanapt® generated first ex-U.S. product revenue WASHINGTON , Oct.
Sign-up for - Vanda Pharmaceuticals Reports Third Quarter 2014 Financial Results investment picks
2014/10/27
SHENZHEN, China , Oct.
Sign-up for 2014/10/27 - CNIT Entered Strategic Partnership with Pengfeng Investment on Automobile New Media Platform investment picks
Data from Sublingual Sufentanil Development Program Highlights Analgesic Response Compared to IV Morphine in Young vs Elderly Adult Patients REDWOOD CITY, Calif.
Sign-up for - AcelRx Pharmaceuticals Announces Sublingual Sufentanil Data Presentations At The American College Of Surgeons Meeting investment picks
Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia inducible factor (HIF), today announced positive top-line results from its Phase 2b placebo-controlled trial of AKB-6548 in non-dialysis patients with anemia related to chronic kidney disease (CKD). The study achieved its primary endpoint and AKB-6548 was generally well tolerated, confirming that the once-daily, oral therapy can successfully increase and maintain hemoglobin (HGB) levels.
Sign-up for - Akebia Announces Positive Top-Line Results from its Phase 2b Study of AKB-6548 in Non-Dialysis Patients with Anemia Related to Chronic Kidney Disease investment picks
IRVINE, Calif.
Sign-up for - Lombard Medical to Present at Upcoming Investor Conferences investment picks
2014/10/27
Move in recognition of Singapore's growing status as a global centre of excellence for FX trading Company believes Singapore will continue to grow in dominance in the Asia-Pacific FX space over the next five years SINGAPORE , Oct.
Sign-up for 2014/10/27 - Singapore selected by BNY Mellon for new Foreign Exchange Dealing Room investment picks
- Tosedostat Currently in Phase 2 Development for Patients with AML and MDS - - Acquisition Eliminates Potential $209 Million in Future Developmental and Sales Milestone Payments by CTI Under Prior Agreement with Chroma - SEATTLE , Oct.
Sign-up for - CTI Acquires Exclusive Worldwide License to Tosedostat, a Selective Oral Anti-Cancer Therapy investment picks
Conference Call Scheduled for November 12, 2014 at 9:00 ET NETANYA, Israel , Oct.
Sign-up for - Cellcom Israel Schedules Third Quarter 2014 Results Release For November 12, 2014 investment picks
Project represents an estimated 15 million dollar investment in the community ST.
Sign-up for - Centene Announces Site Selection For New Claims processing Facility In Ferguson investment picks
By Sue Chang, MarketWatch SAN FRANCISCO (MarketWatch)--Among the companies whose shares are expected to see active trading in Monday's session are Twitter Inc., Merck & Co., and Allergan Inc. Twitter(TWTR) is projected to report third-quarter earnings of a penny a share, according to a consensus survey by FactSet.
Sign-up for - UPDATE: Twitter, Merck, Allergan earnings in focus investment picks
By Wallace Witkowski, MarketWatch SAN FRANCISCO (MarketWatch)--Earnings from the energy and health care sectors will dominate investor attention as respective heavyweights report following a week where upside earnings surprises lifted the broader market out of a slump.
Sign-up for - UPDATE: Energy, health care earnings to dominate week investment picks
2014/10/26
SINGAPORE and PORT MORESBY, Papua New Guinea , Oct.
Sign-up for 2014/10/26 - Investor Presentation Update investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1154031&ProfileId=051205&sourceType=1 JERSEY, CHANNEL ISLANDS --
Sign-up for - Tongon action plan to deliver performance upturn investment picks
2014/10/26
The second annual Life Time Tri Oceanside crowned Alicia Kaye and Joe Malloy as winners today in beautiful Oceanside, California.
Sign-up for 2014/10/26 - Joe Malloy and Alicia Kaye Are Top Finishers at Life Time Tri Oceanside Oct. 26 investment picks
-Only Rentrak Provides the Official Global Movie Results- LOS ANGELES , Oct.
Sign-up for - Rentrak Announces Official Worldwide Box Office Results for Weekend of October 26, 2014 investment picks
2014/10/26
- ICL's Performance Products segment to divest its Germany-based APW business as part of ICL's strategy to focus on its core businesses in agriculture, food and engineered materials - TOKYO and TEL AVIV, Israel , Oct.
Sign-up for 2014/10/26 - Kurita To Acquire Aluminium, Paper Chemicals And Water Treatment Businesses (APW) From ICL investment picks
Orbital Sciences Corporation (NYSE:ORB), one of the world’s leading space technology companies, today announced that it is prepared to launch the company’s Antares TM rocket carrying a Cygnus TM cargo logistics spacecraft destined for the International Space Station (ISS) under the Commercial Resupply Services (CRS) contract with NASA.
Sign-up for - Orbital Set to Launch Cargo Delivery Mission to International Space Station investment picks
High Density Compute Platforms Deliver Extreme Performance, Efficiency and Scalability DENVER , Oct.
Sign-up for - Supermicro® Exhibits New X10 6U 28x DP E5-2600 v3 MicroBlade and 1U 3x GPU SuperServer® for Exploration Geophysics at SEG 2014 investment picks
2014/10/25
The formula for the past 17 beers in the Jewbelation series has been simple: Add a malt, a hop and a percentage point of alcohol content for each year.
Sign-up for 2014/10/25 - UPDATE: 10 beers you'll be drinking all winter -2- investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: - ANI Pharmaceuticals Schedules Conference Call for Third Quarter 2014 Financial Results to 2014/10/25 - UPDATE: 10 beers you'll be drinking all winter -2-
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent